Puppin Chaves Fulber on Muck Rack

Puppin Chaves Fulber

As seen in: MDPI
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Puppin Chaves

Contact Puppin Chaves, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Enabling mRNA Therapeutics: Current Landscape and Challenges in Manufacturing

|
By Amine A. Kamen, Maryam Youssef, Cynthia Hitti, Puppin Chaves Fulber
| MDPI
1. Introduction From the first demonstration of messenger RNA (mRNA) delivery into in vivo models [1] to the development of lipid nanoparticles using ionizable lipids as a delivery system for the first approved siRNA therapeutic [2], decades of fundamental research converged to enable the creation of feasible RNA vaccines and therapeutics.
Open in Who Shared Issue with article?
See all 1 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified